Economic Evaluation of an Extended Acellular Pertussis Vaccine Program for Adolescents in Québec, Canada

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.7, Iss.2, 2005-01, pp. : 123-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada

By Iskedjian M. Einarson T.R.

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 551-563

Adis International

Access to resources Recommend Favorite

New acellular pertussis vaccine superior in Ontario, Canada

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 319, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Acellular pertussis vaccine protects adolescents, adults

Inpharma, Vol. 1, Iss. 1510, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Acellular Pertussis Vaccine Safety and Efficacy in Children, Adolescents and Adults

By Casey Janet R. Pichichero Michael E.

Drugs, Vol. 65, Iss. 10, 2005-01 ,pp. : 1367-1389

Adis International

Access to resources Recommend Favorite

Acellular pertussis vaccine at birth induces early immunogenicity

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite